Susquehanna Raises Lam Research Price Target: Here's Why
Susquehanna Financial Group has revised its price target for semiconductor equipment manufacturer Lam Research upward. The firm set the new target price citing the company's strong position in the industry and expectations of rising demand.
Analysts highlight Lam Research's critical role, particularly in memory and logic chip production. The company's recent order flow and technological innovations support its growth potential.
Susquehanna's raised price target could increase investor interest in Lam Research shares. However, market conditions and competition in the sector are among the factors that could affect the company's performance.
This is not an investment recommendation.
📊 LRCX — Piyasa Yorumu
▼ down · 70%The stock experienced a sharp decline of nearly 17% in its last close, with technical indicators pointing to weakness. The RSI stands at 35, approaching oversold territory but not yet signaling a recovery. The MACD line is below the signal line and in negative territory, indicating weak short-term momentum. The price is trading below both the 20-day and 50-day moving averages, confirming a downtrend. Although Susquehanna's target price upgrade is positive news, the deterioration in the technical outlook and the significant drop suggest that selling pressure may persist in the near term.
RSI 14
35.1
MACD
-12.86
24h Δ
-16.97%
Canlı Grafikler
🔗 İlgili haberler
⭐ 67 · 5 gün önce
Advanced Energy Hisse Senedi, Yonga Ekipman Şirketinin Notu Yükseltilmesiyle Alım Noktasına Yaklaştı
⭐ 67 · 6 gün önce
Lam Research ve Çip Ekipmanı Hisseleri Rekor Kırdı
⭐ 76 · 29.06
Lam Research Hedef Fiyatı 150 Dolar Artırıldı: Çip Ekipman Harcamaları 250 Milyar Dolara Koşuyor
⭐ 76 · 29.06
Citi, Lam Research Hedef Fiyatını 135 Dolar Artırdı: Çip Üretim Yatırımı Patlaması Bekliyor
⭐ 67 · 29.06
BofA, Lam Research İçin Hedef Fiyatı Yükseltti, 'Al' Tavsiyesini Korudu
⭐ 85 · 25.06
ABD, Robert Friedland'ın Çip Girişimine 250 Milyon Dolar Yatırım Yapacak
🧬 Buna benzer
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.